Supplement to "Seminars in Oncology" devoted to NovoTTF-100A.
This supplement publishes 4 research papers on the Novocure NovoTTf100-A system. The registry data which I mentioned a few weeks ago is officially published now. Other papers include an analysis of how patients respond over time. It shows that in half of the responders, the first MRI taken after starting treatment looked worse, then started looking better 5months later. The point is not to stop therapy too soon.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.seminoncol.org/issue/S0093-7754(14)X0012-6
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines